Koers Bristol-Myers Squibb Company Borsa Italiana
Aandelen
4BMY
US1101221083
Farmaceutische producten
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
39,16 EUR | -2,74% | -2,54% | -13,21% |
14:04 | Bristol-Myers Squibb kondigt strategieën aan om de toegang tot medicijnen te verbeteren | MT |
11:38 | Bristol-Myers Squibb investeert in NeoPhore | MT |
Omzet 2024 * | 46,03 mld. 42,47 mld. | Omzet 2025 * | 46,06 mld. 42,5 mld. | Marktkapitalisatie | 85,69 mld. 79,06 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -5,41 mld. -5 mld. | Nettowinst (verlies) 2025 * | 10,22 mld. 9,43 mld. | EV/omzet 2024 * | 2,72 x |
Nettoschuld 2024 * | 39,31 mld. 36,28 mld. | Nettoschuld 2025 * | 32,04 mld. 29,56 mld. | EV/omzet 2025 * | 2,56 x |
K/w-verhouding 2024 * |
-16,1
x | K/w-verhouding 2025 * |
8
x | Werknemers | 34.100 |
Dividendrendement 2024 * |
5,69% | Dividendrendement 2025 * |
5,98% | Vrij verhandelbaar | 69,27% |
Recentste transcriptie over Bristol-Myers Squibb Company
1 dag | -2,82% | ||
1 week | -2,54% | ||
Lopende maand | -3,30% | ||
1 maand | -11,19% | ||
3 maanden | -12,55% | ||
6 maanden | -9,91% | ||
Lopend jaar | -13,21% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 53 | 01-02-15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01-04-16 |
Derica Rice
BRD | Director/Board Member | 59 | 01-09-20 |
Datum | Koers | Variatie |
---|---|---|
17-05-24 | 40,27 | +0,07% |
21-05-24 | 39,42 | -2,40% |
20-05-24 | 40,4 | +0,31% |
17-05-24 | 40,27 | +0,07% |
16-05-24 | 40,24 | -2,44% |
slotkoers Borsa Italiana, 17 mei 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+36,89% | 723 mld. | |
+31,14% | 598 mld. | |
-3,35% | 364 mld. | |
+20,11% | 331 mld. | |
+4,00% | 288 mld. | |
+15,96% | 244 mld. | |
+9,78% | 210 mld. | |
-5,03% | 208 mld. | |
+8,81% | 169 mld. |